Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Tasimelteon
Placebo
Locations
3
United States
Vanda Investigational Site
Alameda, California, United States
Vanda Investigational Site
Santa Monica, California, United States
Vanda Investigational Site
Chevy Chase, Maryland, United States
Start Date
July 1, 2016
Primary Completion Date
November 1, 2017
Completion Date
November 1, 2017
Last Updated
November 3, 2021
Lead Sponsor
Vanda Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions